Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Henriette Kissi Anzouan-Kacou"'
Autor:
Thér egrave, Dimitri Hatrydt Kouamé, Alain Attia, se Ndri Yoman, Yannick Mfupa Tchana, Aboubakar Demba Bangoura, Henriette Kissi Anzouan-Kacou, Mahassadi Kouamé Alassan, Stanislas Doffou, Fulgence Bathaix Yao
Publikováno v:
Open Journal of Gastroenterology. :193-201
Context and Aim: Direct-acting antivirals are the therapeutic revolution in the management of viral hepatitis C, but often with a few cases of failure. The aim of this study was to identify factors that may be implicated in the failure of direct-acti
Autor:
Aristide Tchimou, Henriette Kissi Anzouan-Kacou, Stanislas Doffou, Aboubakar Demba Bangoura, D. H. Kouamé, Karidiatou Diallo, Alain Attia, Fulgence Bathaix Yao, Mahassadi Kouamé Alassan, Thérèse Ndri Yoman
Publikováno v:
Open Journal of Gastroenterology. :206-215
The aim of this study was to identify the risk factors of mother-to-child transmission of HBV in positive Ag Hbs pregnant women in Cote d’Ivoire. Methods: This was a transversal prospective study that took place over a period of 7 months (from Febr
Autor:
Mamert Fulgence Yao Bathaix, Djenabou Diallo, Adjeka Stanislas Doffou, Aboubacar Demba Bangoura, Henriette Kissi Anzouan-Kacou, Alassan Kouamé Mahassadi, Aya Thérèse Ndri-Yoman, Hartrydt Dimitri Kouamé, Alain Attia, Yacouba Adéhouni
Publikováno v:
Open Journal of Gastroenterology. :65-74
Background: In the Ivory Coast, chronic infection by hepatitis B and C virus is the leading cause of cirrhosis and hepatocellular carcinoma. The absence of universal health coverage makes the treatment inaccessible to all. Objectives: To assess the e
Autor:
Yacouba Adéhouni, Ya Henriette Kissi Anzouan-Kacou, Adjeka Stanislas Doffou, Fulgence Yao Bathaix, Aya Thérèse Ndri-Yoman, Hatrydt Dimitri Kouamé, Koffi Alain Attia, Djeinabou Diallo, Demba Bangoura, Alassan Kouamé Mahassadi
Publikováno v:
Open Journal of Gastroenterology. :39-45
Little data exist on patients treated with tenofovir in Sub-Saharan Africa. Objective: To describe the clinical and laboratory characteristics of patients with viral hepatitis B treated with tenofovir. Material and methods: A descriptive single-cente